Skip to the page Skip to guide contents Care, from a distance A plain-language online-care guide Guide contents Source notes Read the record behind the claim. Start with the source that answers your question. A rule, a study and a sales claim are different kinds of information. Read the date before drawing a conclusion For a rule, check when it applies, which state it covers and which medicine or kind of care it concerns. For a study, look for completed results. For a quote, look for what the payment actually covers. Ask the person providing your care to explain what a source means for your health problem. One document may answer only part of your question. Read the medicine record Approval and ingredient rules The Food and Drug Administration (FDA) keeps the medicine approval and compounding records. As of September 2026, BPC-157 had no US approval. Taking back a request to use it did not let pharmacies make medicine from its raw ingredients for individual patients. [A] Look for the product or ingredient named in a record. A code, registration or meeting notice is a different kind of record from an approval. Human evidence and its limits As of September 2026, FDA’s human-study review counted five studies, including small reports without a comparison group. [A] A report of improvement is not enough to show the cause of that improvement. Read what was actually compared. Ask whether the study involved people with the concern you bring to care. Quality papers and unknown effects FDA’s review, checked in September 2026, described papers for BPC-157 without an added salt, known as the free-base form. Most reported the sample’s BPC-157 content but gave no test results for unwanted substances. [A] That is a limit on what the paper shows, rather than proof that every medicine is contaminated. FDA says a problem report cannot establish that the medicine caused it, or provide a basis for estimating how often it occurs. [E] Read the record for the proposed care Visit guidance and licences A group of US medical boards forms the Federation of State Medical Boards. It publishes advice for state boards; that advice is not itself law. [B] As of September 2026, US guidance required a doctor to be licensed or otherwise permitted where the patient is during the visit. [C] The state board’s public record shows a doctor’s current licence status, along with any action taken for breaking professional rules. [D] Why this guide has no clinic prices As of September 2026, BPC-157 had no approved medicine with a maker’s published price or a government’s published price. [A] Use a written quote to ask about the proposed care. Keep unanswered charges visible on the question sheet. Page notes [A] FDA’s detailed BPC-157 briefing [B] Medical-board guidance on prescribing and patient questions [C] HHS guidance on permission to practise and patient location [D] Find the state medical board for the licence record [E] FDA’s limits on interpreting problem reports [F] FDA’s pharmacy licence lookup Continue with the next question First look Find your next question The guide, at a glance. Begin at the first look, or turn straight to the part of care on your mind. Get your bearings First look What the substance is Before the visit Follow the care process The prescribing decision Questions about tests Check the pharmacy After the visit Work through the details Paying for care When to pause Common questions Source notes These pages help make sense of online care. The site is a guide and does not operate a clinic or sell treatment. Read this page as text Text guide index